Withdraw Application of oral nutrition supplements in patients at nutritional risk after surgery for gastric cancer: A prospective, randomized, control clinical

Application of oral nutrition supplements in patients at nutritional risk after surgery for gastric cancer: A prospective, randomized, control clinical trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900026630

Enrollment

Unknown

Registered

2019-10-16

Start date

2019-10-01

Completion date

Unknown

Last updated

2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

ONS group:patients received dietary advice and oral intake of Nutren Optimum (Nestle Health Science, Switzerland) at a dosage of 500 mL daily for 3 months after discharge as a supplement to regular me

Control group:General dietary

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients were enrolled if they discharged after surgery for gastric cancer and had nutritional risk score at 3 or greater based on the nutritional risk screening 2002 (NRS-2002) tool

Exclusion criteria

Exclusion criteria: Participants were excluded if they were unable to take food orally, already on nutritional support therapy, pregnant, or under age 18.

Design outcomes

Primary

Measure	Time frame
body weight;body mass index;skeletal muscle index;serum hemoglobin level;serum albumin level;chemotherapy tolerance;quality of life;	—

Secondary

Measure	Time frame
The 90-day readmission;the power of gripping;	—

Countries

China

Contacts

Public ContactGuohao Wu

Zhongshan Hospital, Fudan University

prowugh@163.com+86 13901666088

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026